Immunohistochemical detection of p21(WAF1/CIP1) and p53 proteins in formalin-fixed paraffin-embedded tissue sections of squamous cell carcinoma of the skin

Journal of Dermatological Science

Volumn 14, Issue 3, 1997, Pages 233-239

  Matsuta, Mayumi ^a   Kon, Saiichi ^a   Sasaki, Kohsuke ^a   Matsuta, Morimasa ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell cycle; Immunohistochemistry; p21; p53; Squamous cell carcinoma

Indexed keywords

PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; FIXATIVE; FORMALDEHYDE; MONOCLONAL ANTIBODY; PARAFFIN;

ARTICLE; CELL CYCLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; BIOPSY; CHEMISTRY; IMMUNOLOGY; METHODOLOGY; PATHOLOGY; SKIN; SKIN TUMOR;

ANTIBODIES, MONOCLONAL; BIOPSY; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FIXATIVES; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; PARAFFIN EMBEDDING; SKIN; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031081959     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(96)00579-8     Document Type: Article

References (16)

1. [1] El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM Lin D, Mercer WE, Kizler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
2. [2] Murrray AW: Creative blocks: cell-cycle checkpoints and feedback controls. Nature 359: 599-604, 1992.
3. [3] Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Glvol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395, 1994.
4. [4] Steinman RA, Hoffman B, Iro A, Guillouf C, Libermann DA, El-Houseini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396, 1994.
5. [5] Jiang H, Lin J, Su Z-Z, Collart FR, Huberman E, Fisher P: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406, 1994.
6. [6] Nagano T, Ueda M, Ichihashi M: Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch Dermatol 129: 1157-1161, 1993.
7. [7] Nelson MA, Einspahr JG, Alberts DS, Balfour CA, Wymer JA, Welchn KL, Salasche SJ, Bangert JL, Grogan TM, Bozzo PO: Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 30: 23-29, 1994.
8. [8] Lee YS, Teh M: p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin. Cancer 73: 2317-2323, 1994.
9. [9] Hughes JH, Robinson RA: p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin. Mod Pathol 8: 526-529, 1995.
10. [10] Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP: Abscence of WAF1 mutations in a variety of human malignancies. Blood 84: 3781-3784, 1994.
11. [11] Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The 21 cdk-interacting protein cip 1 is a protein inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
12. [12] Pines J: p21 inhibits cyclin shock. Science 369: 520-521, 1994.
13. [13] El-Deiry W, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell MH, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B: WAF1/CIP1 is induced in p-53 mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994.
14. [14] El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B: Topological control of p21WAF/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919, 1995.
15. [15] Ohue M, Tomita N, Monden T, Fujita M, Fukunaga M, Takami K, Yana I, Ohnish T, Enomoto T, Inoue M, Shimano T, Mori T: A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res 54: 4798-4804, 1994.
16. [16] Eyfjörd JE, Thorlacius S, Steinarsdottir M, Valgardsdottir R, Ogmundsdottir HM, A-Jonsson K: p53 abnormalities and genomic instability in primary human breast carcinoma. Cancer Res 55: 646-651, 1995.